MedTech Startup Employs AI to Detect Respiratory Issues In Kids
Wed, April 21, 2021

MedTech Startup Employs AI to Detect Respiratory Issues In Kids

StethoMe's AI-powered stethoscope will help detect respiratory maladies in children/Photo Credit: Panchenko Vladimir (via Shutterstock)


MedTech startup StethoMe, based in the city of Poznan, Poland, developed an AI-powered smart stethoscope that can detect, classify, and analyze pathological sounds in children’s lungs, according to Nicholas Fearn of American business magazine Forbes. The startup claimed that the stethoscope has the potential to boost the accuracy of results and analysis by up to 13%. 

The technology will give parents peace of mind when examining their children at home and provide more “accurate readings” for health professionals. “The healthcare challenge we are tackling is the lack of remote auscultation and the poor accuracy and subjectiveness of this kind of examination,” CEO Wojciech Radomski explained. Presently, there is no objective method for diagnosing lung ailments at home, he added. 

Without any sort of solution, monitoring chronic respiratory ailments will be more difficult. Notably, the AI algorithms in the technology have helped doctors diagnose respiratory diseases, Radomski noted. So, how does the electronic stethoscope work? First, it will connect to a user’s person via Bluetooth. Then, the stethoscope will use AI algorithms to detect abnormalities in children’s respiratory systems. If something abnormal is detected, the results can be relayed to a professional for remote consultation.

“These are shared directly with a doctor in order to support them with more accurate disease diagnosis, or inform parents that everything is as it should be without the need for immediate action.”  Aside from peace of mind for patients, it will ease the burden on doctors by minimizing the number of unnecessary hospital visits or GPs. 

The stethoscope can help professionals track the course of treatment, monitor any reactions to medicines, and make adjustments to treatment “following a traditional visit or hospitalization.” Since the stethoscope has undergone testing, Radomski and his colleagues are now ready to launch the technology commercially. 

Radomski confidently declared that they are “fully prepared.” They also noted that they have successfully integrated their solution into “existing telemedicine platforms, hospital information systems, electronic health records and Insurance systems.”